Viosera Therapeutics

Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria.

Launch date

Jul 2016

Employees

Market cap

Enterprise valuation

CAD3m (Public information from Mar 2019)

Sunnyvale California (HQ), San Francisco United States (HQ)

https://www.viosera.com/

https://twitter.com/vioseratherapy https://www.linkedin.com/company/viosera-therapeutics

Authorizing premium user...